Clinical trials
Urinary Tract Infections (UTIs) clinical trials
Below are recruiting urinary tract infections (utis) clinical trials, each written for real people, not researchers. We’re tracking 61 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06719232Recruiting
Testing a new way to give bladder treatment without a catheter
This study tests a catheter-free method for delivering medication directly into the bladder. It may help patients with bladder pain, recurrent infections, bladder cancer, or cystitis after radiation or chemotherapy.
BudapestAges 18–80 - NCT07184827RecruitingPhase 3
U101 capsules to prevent recurring UTIs in women
This trial tests an oral capsule called U101 to see if it can prevent recurrent urinary tract infections (UTIs) in women who have frequent UTIs. If you've had at least 2 UTIs in the last 6 months or 3 in the last year, you may be able to join.
Kaohsiung CityAges 20–75 - NCT07186465RecruitingPhase 4
Preventing repeat bladder infections in postmenopausal women
This trial tests two approaches to prevent repeat bladder infections in postmenopausal women: a daily antibiotic pill or a vaginal tablet containing healthy bacteria and estrogen. The goal is to see which method works better over 6 months.
Bangkok, Phayatai RatchathewiAges 40 years+ - NCT07308808RecruitingEarly Phase 1
Safety of a live bacteria solution for bladder infections
This trial tests if putting a live bacteria called Lactobacillus crispatus into the bladder is safe for people with spinal cord injury and neurogenic lower urinary tract dysfunction. It may help prevent urinary tract infections without antibiotics.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06106204Enrolling by invitation
Reducing antibiotic use after hospital discharge
This study looks at ways to reduce unnecessary antibiotic use when patients are discharged from the hospital after being treated for a UTI or pneumonia. It aims to help you avoid taking antibiotics longer than needed.
Salt Lake City, UtahAges 18 years+ - NCT06822010RecruitingPhase 2
Gemcitabine and Mitomycin for High-Risk Upper Tract Cancer
This trial tests a combination of two chemotherapy drugs, gemcitabine and mitomycin, given directly into the kidney or ureter through a thin tube. It is for people with a high-risk but non-invasive form of upper urinary tract cancer that has not spread into deeper tissues.
New Brunswick, New JerseyAges 18–99 - NCT06774131RecruitingPhase 3
Study of UGN-104 for low-grade upper tract urothelial cancer
This trial tests a new treatment called UGN-104 for people with low-grade upper tract urothelial cancer (a type of cancer in the tube that carries urine from the kidney to the bladder). The treatment is given directly into the kidney area to kill cancer cells without surgery.
Homewood, AlabamaAges 18 years+ - NCT07425015Recruiting
24-hour bladder monitoring study
This study uses a new device to measure your bladder function over a full day, helping doctors better understand urinary symptoms. You might be eligible if you need a standard bladder test and do not have certain conditions like frequent infections or nerve-related bladder problems.
Hanover, MarylandAges 22 years+ - NCT07372547Recruiting
Does Shower Standing Help Women Empty Bladder After Catheter Removal?
This trial compares standing in the shower versus sitting on a toilet to see which position helps women empty their bladder more completely after a urinary catheter is removed following vaginal surgery.
AshdodAges 18–99 - NCT07494864Recruiting
Urinary tract health and microbiome study
This study looks at how bacteria and the immune system affect the lower urinary tract. It includes healthy volunteers and people with various urinary conditions, like infections or bladder pain.
Zurich, Canton of ZurichAges 18 years+ - NCT07485205Recruiting
Bladder pressure study in healthy adults
This study collects normal bladder pressure data from healthy adults using a new device. It helps doctors understand what healthy bladder function looks like, which may improve future care.
Phoenix, ArizonaAges 18–45 - NCT04627701Recruiting
Omega System for symptom relief in enlarged prostate
This trial tests whether the Omega System is safe and effective for improving symptoms from an enlarged prostate (BPH). It looks for men with bothersome urine symptoms and certain prostate size/flow measurements, while carefully excluding prostate cancer and other conditions that could interfere or be unsafe.
BeershebaAges 50 years+ - NCT05757687Recruiting
Omega System for urinary symptoms from enlarged prostate
This trial studies a device called the Omega System to see if it is safe and effective for urinary problems caused by an enlarged prostate (BPH). You may be a better fit if you have moderate-to-severe symptoms and prostate measurements that match the study plan, and if you are scheduled for prostate surgery or need evaluation for BPH.
TbilisiAges 50 years+
Hear when a new Urinary Tract Infections (UTIs) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for urinary tract infections (utis)?
- Yes. Clin2 currently lists 61 recruiting urinary tract infections (utis) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a urinary tract infections (utis) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a urinary tract infections (utis) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.